{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:41Z","timestamp":1773379601279,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/MED\/30\/VNCI-Hr-BRCA\/2015"],"award-info":[{"award-number":["BT\/MED\/30\/VNCI-Hr-BRCA\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A preoperative-progesterone intervention increases disease-free survival in patients with breast cancer, with an unknown underlying mechanism. We elucidated the role of non-coding RNAs in response to progesterone in human breast cancer.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Whole transcriptome sequencing dataset of 30 breast primary tumors (10 tumors exposed to hydroxyprogesterone and 20 tumors as control) were re-analyzed to identify differentially expressed non-coding RNAs followed by real-time PCR analyses to validate the expression of candidates. Functional analyses were performed by genetic knockdown, biochemical, and cell-based assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified a significant downregulation in the expression of a long non-coding RNA, <jats:italic>Down syndrome cell adhesion molecule antisense DSCAM-AS1<\/jats:italic>, in response to progesterone treatment in breast cancer. The progesterone-induced expression of <jats:italic>DSCAM-AS1<\/jats:italic> could be effectively blocked by the knockdown of progesterone receptor (PR) or treatment of cells with mifepristone (PR-antagonist). We\u00a0further show that knockdown of <jats:italic>DSCAM-AS1<\/jats:italic> mimics the effect of progesterone in impeding cell migration and invasion in PR-positive breast cancer cells, while its overexpression shows an opposite effect. Additionally, <jats:italic>DSCAM-AS1<\/jats:italic> sponges the activity of <jats:italic>miR-130a<\/jats:italic> that regulates the expression of <jats:italic>ESR1<\/jats:italic> by binding to its 3\u2019-UTR\u00a0to mediate the effect of progesterone in breast cancer cells. Consistent with our findings, TCGA analysis suggests that high levels of <jats:italic>miR-130a<\/jats:italic> correlate with a tendency toward better overall survival in patients with breast cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study presents a mechanism involving the <jats:italic>DSCAM-AS1\/miR-130a\/ESR1<\/jats:italic> genomic axis through which progesterone impedes breast cancer cell invasion and migration. The findings highlight the utility of progesterone treatment in impeding metastasis and improving survival outcomes in patients with breast cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13058-022-01597-x","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T15:03:49Z","timestamp":1672239829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Progesterone modulates the DSCAM-AS1\/miR-130a\/ESR1 axis to suppress cell invasion and migration in breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Neelima","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roma","family":"Sunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhasker","family":"Dharavath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Chandrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukul","family":"Godbole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Dutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"1","key":"1597_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","volume":"107","author":"A Fournier","year":"2008","unstructured":"Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103\u201311.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1597_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/bcr1659","volume":"9","author":"DJ Jerry","year":"2007","unstructured":"Jerry DJ. Roles for estrogen and progesterone in breast cancer prevention. Breast Cancer Res. 2007;9(2):102.","journal-title":"Breast Cancer Res"},{"issue":"Suppl 1","key":"1597_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/13697137.2013.768806","volume":"16","author":"H Kuhl","year":"2013","unstructured":"Kuhl H, Schneider HP. Progesterone\u2013promoter or inhibitor of breast cancer. Climacteric. 2013;16(Suppl 1):54\u201368.","journal-title":"Climacteric"},{"key":"1597_CR4","doi-asserted-by":"crossref","unstructured":"Barchiesi G, Mazzotta M, Krasniqi E, Pizzuti L, Marinelli D, Capomolla E, Sergi D, Amodio A, Natoli C, Gamucci T, et al. Neoadjuvant endocrine therapy in breast cancer: current knowledge and future perspectives. Int J Mol Sci 2020;21(10).","DOI":"10.3390\/ijms21103528"},{"issue":"5","key":"1597_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJMe2109356","volume":"385","author":"PJ Goodwin","year":"2021","unstructured":"Goodwin PJ. Extended aromatase inhibitors in hormone-receptor-positive breast cancer. N Engl J Med. 2021;385(5):462\u20133.","journal-title":"N Engl J Med"},{"issue":"4","key":"1597_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4048\/jbc.2012.15.4.434","volume":"15","author":"AI Kucuk","year":"2012","unstructured":"Kucuk AI, Atalay C. The relationship between surgery and phase of the menstrual cycle affects survival in breast cancer. J Breast Cancer. 2012;15(4):434\u201340.","journal-title":"J Breast Cancer"},{"issue":"8752","key":"1597_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/0140-6736(91)92927-T","volume":"337","author":"RA Badwe","year":"1991","unstructured":"Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD, Fentiman IS. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 1991;337(8752):1261\u20134.","journal-title":"Lancet"},{"issue":"8912","key":"1597_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(94)92942-4","volume":"343","author":"U Veronesi","year":"1994","unstructured":"Veronesi U, Luini A, Mariani L, Del Vecchio M, Alvez D, Andreoli C, Giacobone A, Merson M, Pacetti G, Raselli R, et al. Effect of menstrual phase on surgical treatment of breast cancer. Lancet. 1994;343(8912):1545\u20137.","journal-title":"Lancet"},{"issue":"20","key":"1597_CR9","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1200\/JCO.2015.62.6630","volume":"34","author":"N Wolmark","year":"2016","unstructured":"Wolmark N, Mamounas EP, Baehner FL, Butler SM, Tang G, Jamshidian F, Sing AP, Shak S, Paik S. Prognostic impact of the combination of recurrence score and quantitative estrogen receptor expression (ESR1) on predicting late distant recurrence risk in estrogen receptor-positive breast cancer after 5 years of tamoxifen: results from NRG Oncology\/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14. J Clin Oncol. 2016;34(20):2350\u20138.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1597_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1158\/0008-5472.CAN-21-2576","volume":"82","author":"Z Li","year":"2022","unstructured":"Li Z, Wu Y, Yates ME, Tasdemir N, Bahreini A, Chen J, Levine KM, Priedigkeit NM, Nasrazadani A, Ali S, et al. Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Res. 2022;82(7):1321\u201339.","journal-title":"Cancer Res"},{"key":"1597_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.matbio.2015.02.008","volume":"43","author":"P Bouris","year":"2015","unstructured":"Bouris P, Skandalis SS, Piperigkou Z, Afratis N, Karamanou K, Aletras AJ, Moustakas A, Theocharis AD, Karamanos NK. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells. Matrix Biol. 2015;43:42\u201360.","journal-title":"Matrix Biol"},{"issue":"2","key":"1597_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10549-016-4007-5","volume":"160","author":"A Nordenskjold","year":"2016","unstructured":"Nordenskjold A, Fohlin H, Fornander T, Lofdahl B, Skoog L, Stal O. Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2016;160(2):313\u201322.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1597_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-017-0330-z","volume":"40","author":"M Godbole","year":"2017","unstructured":"Godbole M, Tiwary K, Badwe R, Gupta S, Dutt A. Progesterone suppresses the invasion and migration of breast cancer cells irrespective of their progesterone receptor status\u2014a short report. Cell Oncol. 2017;40(4):411\u20137.","journal-title":"Cell Oncol"},{"issue":"3","key":"1597_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/ijmm.2017.3060","volume":"40","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zhou W, Zhang H, Hu Y, Yu L, Zhang Y, Zhang Y, Wang S, Wang P, Xia W. Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor alpha. Int J Mol Med. 2017;40(3):755\u201361.","journal-title":"Int J Mol Med"},{"issue":"1","key":"1597_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1021\/acs.jproteome.7b00754","volume":"17","author":"JM Azeez","year":"2018","unstructured":"Azeez JM, Vini R, Remadevi V, Surendran A, Jaleel A, Santhosh Kumar TR, Sreeja S. VDAC1 and SERCA3 mediate progesterone-triggered Ca2(+) signaling in breast cancer cells. J Proteome Res. 2018;17(1):698\u2013709.","journal-title":"J Proteome Res"},{"issue":"12","key":"1597_CR16","first-page":"4835","volume":"30","author":"R Fjelldal","year":"2010","unstructured":"Fjelldal R, Moe BT, Orbo A, Sager G. MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486). Anticancer Res. 2010;30(12):4835\u201340.","journal-title":"Anticancer Res"},{"key":"1597_CR17","first-page":"5987","volume":"9","author":"JM Azeez","year":"2015","unstructured":"Azeez JM, Sithul H, Hariharan I, Sreekumar S, Prabhakar J, Sreeja S, Pillai MR. Progesterone regulates the proliferation of breast cancer cells\u2014in vitro evidence. Drug Des Devel Ther. 2015;9:5987\u201399.","journal-title":"Drug Des Devel Ther"},{"issue":"7560","key":"1597_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature14583","volume":"523","author":"H Mohammed","year":"2015","unstructured":"Mohammed H, Russell IA, Stark R, Rueda OM, Hickey TE, Tarulli GA, Serandour AA, Birrell SN, Bruna A, Saadi A, et al. Progesterone receptor modulates ERalpha action in breast cancer. Nature. 2015;523(7560):313\u20137.","journal-title":"Nature"},{"issue":"3","key":"1597_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199\u2013208.","journal-title":"Nat Genet"},{"issue":"5","key":"1597_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","volume":"1","author":"JR Prensner","year":"2011","unstructured":"Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391\u2013407.","journal-title":"Cancer Discov"},{"issue":"4","key":"1597_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molcel.2015.06.023","volume":"59","author":"M Sun","year":"2015","unstructured":"Sun M, Gadad SS, Kim DS, Kraus WL. Discovery, annotation, and functional analysis of long noncoding rnas controlling cell-cycle gene expression and proliferation in breast cancer cells. Mol Cell. 2015;59(4):698\u2013711.","journal-title":"Mol Cell"},{"issue":"8","key":"1597_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.15252\/embj.201695335","volume":"36","author":"M Portoso","year":"2017","unstructured":"Portoso M, Ragazzini R, Brencic Z, Moiani A, Michaud A, Vassilev I, Wassef M, Servant N, Sargueil B, Margueron R. PRC2 is dispensable for HOTAIR-mediated transcriptional repression. EMBO J. 2017;36(8):981\u201394.","journal-title":"EMBO J"},{"key":"1597_CR23","doi-asserted-by":"crossref","unstructured":"Volders PJ, Verheggen K, Menschaert G, Vandepoele K, Martens L, Vandesompele J, Mestdagh P. An update on LNCipedia: a database for annotated human lncRNA sequences. Nucleic Acids Res 2015;43(Database issue):D174\u2013180.","DOI":"10.1093\/nar\/gku1060"},{"issue":"D1","key":"1597_CR24","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155\u201362.","journal-title":"Nucleic Acids Res"},{"key":"1597_CR25","doi-asserted-by":"crossref","unstructured":"Fridrichova I, Zmetakova I. MicroRNAs contribute to breast cancer invasiveness. Cells 2019;8(11).","DOI":"10.3390\/cells8111361"},{"issue":"11","key":"1597_CR26","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1080\/15476286.2020.1777769","volume":"17","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Yu W, Tang D, Zhou Y, Bi M, Wang H, Zheng Y, Chen M, Li L, Xu X, et al. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer. RNA Biol. 2020;17(11):1590\u2013602.","journal-title":"RNA Biol"},{"key":"1597_CR27","doi-asserted-by":"publisher","first-page":"12791","DOI":"10.1038\/ncomms12791","volume":"7","author":"YS Niknafs","year":"2016","unstructured":"Niknafs YS, Han S, Ma T, Speers C, Zhang C, Wilder-Romans K, Iyer MK, Pitchiaya S, Malik R, Hosono Y, et al. The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. Nat Commun. 2016;7:12791.","journal-title":"Nat Commun"},{"issue":"11","key":"1597_CR28","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1210\/me.2015-1153","volume":"29","author":"P Jonsson","year":"2015","unstructured":"Jonsson P, Coarfa C, Mesmar F, Raz T, Rajapakshe K, Thompson JF, Gunaratne PH, Williams C. Single-molecule sequencing reveals estrogen-regulated clinically relevant lncRNAs in breast cancer. Mol Endocrinol. 2015;29(11):1634\u201345.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"1597_CR29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/15384047.2017.1373216","volume":"18","author":"M Godbole","year":"2017","unstructured":"Godbole M, Chandrani P, Gardi N, Dhamne H, Patel K, Yadav N, Gupta S, Badwe R, Dutt A. miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells. Cancer Biol Ther. 2017;18(10):801\u20135.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"1597_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"1","key":"1597_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41467-019-09649-1","volume":"10","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xue M, Du S, Feng W, Zhang K, Zhang L, Liu H, Jia G, Wu L, Hu X, et al. Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT. Nat Commun. 2019;10(1):1637.","journal-title":"Nat Commun"},{"issue":"3","key":"1597_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41588-019-0562-0","volume":"52","author":"B Rodriguez-Martin","year":"2020","unstructured":"Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, Santamarina M, Ju YS, Temes J, Garcia-Souto D, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52(3):306\u201319.","journal-title":"Nat Genet"},{"key":"1597_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.528520","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Cui Z, Lv X, Li J, Gao M, Yang Z, Bi Y, Zhang Z, Wang S, Li S, et al. Long non-coding RNA HOTAIR function as a competing endogenous RNA for miR-149-5p to promote the cell growth, migration, and invasion in non-small cell lung cancer. Front Oncol. 2020;10: 528520.","journal-title":"Front Oncol"},{"key":"1597_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1476-4598-13-92","volume":"13","author":"XH Liu","year":"2014","unstructured":"Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.","journal-title":"Mol Cancer"},{"issue":"3","key":"1597_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41389-020-0215-2","volume":"9","author":"J Xiao","year":"2020","unstructured":"Xiao J, Lin L, Luo D, Shi L, Chen W, Fan H, Li Z, Ma X, Ni P, Yang L, et al. Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance. Oncogenesis. 2020;9(3):29.","journal-title":"Oncogenesis"},{"issue":"7","key":"1597_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41419-018-0759-7","volume":"9","author":"Y Shan","year":"2018","unstructured":"Shan Y, Ma J, Pan Y, Hu J, Liu B, Jia L. LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1. Cell Death Dis. 2018;9(7):722.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1597_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10549-018-4749-3","volume":"170","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Chaubal R, Maitra A, Gardi N, Dutt A, Gupta S, Badwe RA, Majumder PP, Pandey P. Pre-operative progesterone benefits operable breast cancer patients by modulating surgical stress. Breast Cancer Res Treat. 2018;170(2):431\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1597_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417\u20139.","journal-title":"Nat Methods"},{"issue":"12","key":"1597_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"50","key":"1597_CR40","doi-asserted-by":"publisher","first-page":"19263","DOI":"10.1074\/jbc.RA118.002894","volume":"293","author":"M Godbole","year":"2018","unstructured":"Godbole M, Togar T, Patel K, Dharavath B, Yadav N, Janjuha S, Gardi N, Tiwary K, Terwadkar P, Desai S, et al. Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells. J Biol Chem. 2018;293(50):19263\u201376.","journal-title":"J Biol Chem"},{"issue":"15","key":"1597_CR41","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"9","key":"1597_CR42","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1038\/nprot.2012.101","volume":"7","author":"J Feng","year":"2012","unstructured":"Feng J, Liu T, Qin B, Zhang Y, Liu XS. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7(9):1728\u201340.","journal-title":"Nat Protoc"},{"issue":"7381","key":"1597_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature. 2012;481(7381):389\u201393.","journal-title":"Nature"},{"key":"1597_CR44","doi-asserted-by":"crossref","unstructured":"Kondili M, Fust A, Preussner J, Kuenne C, Braun T, Looso M. UROPA: a tool for Universal RObust Peak Annotation. Sci Rep 2017;7(1).","DOI":"10.1038\/s41598-017-02464-y"},{"issue":"D1","key":"1597_CR45","doi-asserted-by":"publisher","first-page":"D231","DOI":"10.1093\/nar\/gkv1270","volume":"44","author":"MD Paraskevopoulou","year":"2016","unstructured":"Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P, Floros E, Dalamagas T, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44(D1):D231-238.","journal-title":"Nucleic Acids Res"},{"key":"1597_CR46","doi-asserted-by":"crossref","unstructured":"Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 2015;12(8):697.","DOI":"10.1038\/nmeth.3485"},{"issue":"1","key":"1597_CR47","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","volume":"5","author":"AJ Enright","year":"2003","unstructured":"Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol. 2003;5(1):R1.","journal-title":"Genome Biol"},{"key":"1597_CR48","doi-asserted-by":"crossref","unstructured":"Kruger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006;34(Web Server):W451\u2013W454.","DOI":"10.1093\/nar\/gkl243"},{"issue":"1","key":"1597_CR49","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell. 2005;120(1):15\u201320.","journal-title":"Cell"},{"key":"1597_CR50","doi-asserted-by":"crossref","unstructured":"Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 2011;39(Database issue):D163\u2013169.","DOI":"10.1093\/nar\/gkq1107"},{"key":"1597_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0076-6879(89)80091-6","volume":"180","author":"JF Milligan","year":"1989","unstructured":"Milligan JF, Uhlenbeck OC. Synthesis of small RNAs using T7 RNA polymerase. Methods Enzymol. 1989;180:51\u201362.","journal-title":"Methods Enzymol"},{"issue":"7","key":"1597_CR52","doi-asserted-by":"publisher","DOI":"10.2196\/27633","volume":"23","author":"A Lanczky","year":"2021","unstructured":"Lanczky A, Gyorffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res. 2021;23(7): e27633.","journal-title":"J Med Internet Res"},{"issue":"W1","key":"1597_CR53","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"1597_CR54","doi-asserted-by":"crossref","unstructured":"Desai S, Dharavath B, Manavalan S, Rane A, Redhu AK, Sunder R, Butle A, Mishra R, Joshi A, Togar T, et al. Fusobacterium nucleatum is associated with inflammation and poor survival in early-stage HPV-negative tongue cancer. NAR Cancer 2022;4(1):zcac006.","DOI":"10.1093\/narcan\/zcac006"},{"issue":"3","key":"1597_CR55","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.bbrc.2017.03.114","volume":"486","author":"S Yu","year":"2017","unstructured":"Yu S, Kim T, Yoo KH, Kang K. The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer. Biochem Biophys Res Commun. 2017;486(3):752\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1597_CR56","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/mc.22941","volume":"58","author":"WH Liang","year":"2019","unstructured":"Liang WH, Li N, Yuan ZQ, Qian XL, Wang ZH. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Mol Carcinog. 2019;58(4):461\u201373.","journal-title":"Mol Carcinog"},{"issue":"1","key":"1597_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-020-01664-1","volume":"39","author":"H He","year":"2020","unstructured":"He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139\/GDF10 in hepatocellular carcinoma. J Exp Clin Cancer Res CR. 2020;39(1):159.","journal-title":"J Exp Clin Cancer Res CR"},{"issue":"21","key":"1597_CR58","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1200\/JCO.2010.33.0738","volume":"29","author":"R Badwe","year":"2011","unstructured":"Badwe R, Hawaldar R, Parmar V, Nadkarni M, Shet T, Desai S, Gupta S, Jalali R, Vanmali V, Dikshit R, et al. Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. J Clin Oncol. 2011;29(21):2845\u201351.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1597_CR59","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1158\/1078-0432.CCR-10-2950","volume":"17","author":"TN Pathiraja","year":"2011","unstructured":"Pathiraja TN, Shetty PB, Jelinek J, He R, Hartmaier R, Margossian AL, Hilsenbeck SG, Issa JP, Oesterreich S. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients. Clin Cancer Res. 2011;17(12):4177\u201386.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1597_CR60","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1038\/s41467-022-30898-0","volume":"13","author":"V Scabia","year":"2022","unstructured":"Scabia V, Ayyanan A, De Martino F, Agnoletto A, Battista L, Laszlo C, Treboux A, Zaman K, Stravodimou A, Jallut D, et al. Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor. Nat Commun. 2022;13(1):3127.","journal-title":"Nat Commun"},{"issue":"14","key":"1597_CR61","first-page":"7709","volume":"24","author":"CL Yu","year":"2020","unstructured":"Yu CL, Xu NW, Jiang W, Zhang H, Ma Y. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101. Eur Rev Med Pharmacol Sci. 2020;24(14):7709\u201317.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1597_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/CBM-190703","volume":"30","author":"Y Ning","year":"2021","unstructured":"Ning Y, Bai Z. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p\/GPRC5A signaling. Cancer Biomark. 2021;30(1):29\u201339.","journal-title":"Cancer Biomark"},{"issue":"6","key":"1597_CR63","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3892\/ol.2021.13086","volume":"22","author":"L Li","year":"2021","unstructured":"Li L, Chen P, Huang B, Cai P. lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p. Oncol Lett. 2021;22(6):825.","journal-title":"Oncol Lett"},{"issue":"1","key":"1597_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2011.12.020","volume":"355","author":"DR Cochrane","year":"2012","unstructured":"Cochrane DR, Jacobsen BM, Connaghan KD, Howe EN, Bain DL, Richer JK. Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer. Mol Cell Endocrinol. 2012;355(1):15\u201324.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"1597_CR65","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2018.05.018","volume":"501","author":"X Kong","year":"2018","unstructured":"Kong X, Zhang J, Li J, Shao J, Fang L. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells. Biochem Biophys Res Commun. 2018;501(2):486\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1597_CR66","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1002\/jcb.26739","volume":"119","author":"X Chen","year":"2018","unstructured":"Chen X, Zhao M, Huang J, Li Y, Wang S, Harrington CA, Qian DZ, Sun XX, Dai MS. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1. J Cell Biochem. 2018;119(6):4945\u201356.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1597_CR67","first-page":"384","volume":"8","author":"Y Pan","year":"2015","unstructured":"Pan Y, Wang R, Zhang F, Chen Y, Lv Q, Long G, Yang K. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A. Int J Clin Exp Pathol. 2015;8(1):384\u201393.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-022-01597-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-022-01597-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T19:07:42Z","timestamp":1672513662000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-022-01597-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1186\/s13058-022-01597-x","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"19 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}